• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生殖细胞肿瘤:利用氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)和动力学模型鉴别存活肿瘤、成熟畸胎瘤及坏死组织。

Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.

作者信息

Sugawara Y, Zasadny K R, Grossman H B, Francis I R, Clarke M F, Wahl R L

机构信息

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0028, USA.

出版信息

Radiology. 1999 Apr;211(1):249-56. doi: 10.1148/radiology.211.1.r99ap16249.

DOI:10.1148/radiology.211.1.r99ap16249
PMID:10189480
Abstract

PURPOSE

To evaluate the feasibility of positron emission tomography (PET) with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with germ cell tumor (GCT) to monitor treatment and differentiate residual masses after chemotherapy.

MATERIALS AND METHODS

Twenty-six FDG PET studies were performed in 21 patients with GCT, FDG uptake of tumors was interpreted visually, and the lean standardized uptake value (SUVlean) was determined. Tumor kinetic rate constants (K1, k2, k3) and net rate of FDG phosphorylation (K = [K1.k3]/[k2 + k3]) in tumors were calculated from the dynamic data by means of a three-compartment model, assuming k4 = 0.

RESULTS

Viable tumors (n = 10) showed intense FDG uptake and could easily be differentiated visually from mature teratoma (n = 6) and necrosis or scar (n = 10). The SUVlean of residual viable tumors (4.51 +/- 1.34 [mean +/- SD]) was higher than that of mature teratoma (1.38 +/- 0.71) and necrosis or scar (1.05 +/- 0.29) (P < .05). Although neither the visual interpretation nor SUVlean differentiated mature teratoma from necrosis or scar, there were statistically significant differences in the kinetic rate constants K1 and K between mature teratoma and necrosis or scar as follows: K1, 0.113 mL/min/g +/- 0.026 versus 0.036 mL/min/g +/- 0.005 (P < .05); K, 0.005 mL/min/g +/- 0.003 versus 0.0008 mL/min/g +/- 0.0001 (P < .05).

CONCLUSION

FDG PET with kinetic analysis appears to be a promising method for management of disease in patients with GCT after treatment.

摘要

目的

评估采用2-[氟-18]-氟-2-脱氧-D-葡萄糖(FDG)进行正电子发射断层扫描(PET)在生殖细胞肿瘤(GCT)患者中监测治疗及鉴别化疗后残留肿块的可行性。

材料与方法

对21例GCT患者进行了26次FDG PET研究,对肿瘤的FDG摄取情况进行视觉解读,并测定瘦体标准化摄取值(SUVlean)。通过三室模型,假设k4 = 0,根据动态数据计算肿瘤的动力学速率常数(K1、k2、k3)和FDG磷酸化净速率(K = [K1·k3]/[k2 + k3])。

结果

存活肿瘤(n = 10)表现出强烈的FDG摄取,在视觉上很容易与成熟畸胎瘤(n = 6)以及坏死或瘢痕(n = 10)区分开来。残留存活肿瘤的SUVlean(4.51±1.34 [平均值±标准差])高于成熟畸胎瘤(1.38±0.71)和坏死或瘢痕(1.05±0.29)(P <.05)。虽然视觉解读和SUVlean均无法区分成熟畸胎瘤与坏死或瘢痕,但成熟畸胎瘤与坏死或瘢痕之间的动力学速率常数K1和K存在统计学显著差异,如下:K1,0.113 mL/min/g±0.026与0.036 mL/min/g±0.005(P <.05);K,0.005 mL/min/g±0.003与0.0008 mL/min/g±0.0001(P <.05)。

结论

进行动力学分析的FDG PET似乎是治疗后GCT患者疾病管理的一种有前景的方法。

相似文献

1
Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.生殖细胞肿瘤:利用氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)和动力学模型鉴别存活肿瘤、成熟畸胎瘤及坏死组织。
Radiology. 1999 Apr;211(1):249-56. doi: 10.1148/radiology.211.1.r99ap16249.
2
The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.(18)氟-2-脱氧葡萄糖正电子发射断层扫描在睾丸生殖细胞肿瘤化疗后的初始分期和再分期中的作用。
BJU Int. 2002 Apr;89(6):549-56. doi: 10.1046/j.1464-410x.2002.02641.x.
3
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.[18F]氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描及血清肿瘤标志物传统评估方法在非精原细胞性生殖细胞癌患者残余肿块评估中的前瞻性比较
Cancer. 2002 May 1;94(9):2353-62. doi: 10.1002/cncr.10494.
4
Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.正电子发射断层扫描对化疗后生殖细胞肿瘤患者残留影像学异常的评估。
J Clin Oncol. 1996 May;14(5):1637-41. doi: 10.1200/JCO.1996.14.5.1637.
5
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.氟脱氧葡萄糖正电子发射断层扫描在评估复发的生殖细胞肿瘤中的应用
Br J Cancer. 2000 Oct;83(7):863-9. doi: 10.1054/bjoc.2000.1389.
6
FDG PET for detection and therapy control of metastatic germ cell tumor.用于转移性生殖细胞肿瘤检测和治疗控制的氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)
J Nucl Med. 1998 May;39(5):815-22.
7
Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.未经治疗的原发性肺癌和乳腺癌:F-18 FDG动力学速率常数与体外研究结果的相关性
Radiology. 1998 Jun;207(3):767-74. doi: 10.1148/radiology.207.3.9609902.
8
The role of positron emission tomography in germ cell cancer.正电子发射断层扫描在生殖细胞癌中的作用。
World J Urol. 2004 Apr;22(1):41-6. doi: 10.1007/s00345-004-0403-2. Epub 2004 Mar 16.
9
Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?氮-13氨动力学模型能否独立于氟-18氟脱氧葡萄糖来定义心肌活力?
J Am Coll Cardiol. 1997 Mar 1;29(3):537-43. doi: 10.1016/s0735-1097(96)00561-x.
10
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.[(18)F]氟代脱氧葡萄糖正电子发射断层扫描([(18)F] FDG-PET)、计算机断层扫描/磁共振成像(CT/MRI)及肿瘤标志物动力学在转移性生殖细胞肿瘤化疗后残留肿块评估中的作用——管理前景
World J Urol. 2004 Jun;22(2):132-9. doi: 10.1007/s00345-003-0392-6. Epub 2004 Jan 21.

引用本文的文献

1
Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures.核医学成像在非精原细胞瘤生殖细胞肿瘤中的应用:从过去的失败中吸取的教训。
Cancer Imaging. 2024 Nov 18;24(1):156. doi: 10.1186/s40644-024-00794-5.
2
Bidirectional dynamic frame prediction network for total-body [Ga]Ga-PSMA-11 and [Ga]Ga-FAPI-04 PET images.用于全身[镓]Ga-PSMA-11和[镓]Ga-FAPI-04 PET图像的双向动态帧预测网络
EJNMMI Phys. 2024 Nov 4;11(1):92. doi: 10.1186/s40658-024-00698-0.
3
The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
动态 FDG PET/CT 在肺癌鉴别诊断和预测 EGFR 突变中的价值。
BMC Pulm Med. 2024 May 10;24(1):227. doi: 10.1186/s12890-024-02997-9.
4
The role of dynamic, static, and delayed total-body PET imaging in the detection and differential diagnosis of oncological lesions.动态、静态和延迟全身 PET 成像在肿瘤病变的检测和鉴别诊断中的作用。
Cancer Imaging. 2024 Jan 2;24(1):2. doi: 10.1186/s40644-023-00649-5.
5
Current and Future Use of Long Axial Field-of-View Positron Emission Tomography/Computed Tomography Scanners in Clinical Oncology.长轴视野正电子发射断层扫描/计算机断层扫描扫描仪在临床肿瘤学中的当前及未来应用
Cancers (Basel). 2023 Oct 27;15(21):5173. doi: 10.3390/cancers15215173.
6
Alpha-fetoprotein-elevated postpubertal testicular teratoma with retroperitoneal metastasis on F-FDG PET/CT: case report and literature review.青春期后甲胎蛋白升高的睾丸畸胎瘤伴腹膜后转移的F-FDG PET/CT表现:病例报告及文献复习
Front Med (Lausanne). 2023 Sep 5;10:1269587. doi: 10.3389/fmed.2023.1269587. eCollection 2023.
7
Patlak-Ki derived from ultra-high sensitivity dynamic total body [F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients.源自超高灵敏度动态全身[F]FDG PET/CT的Patlak-Ki与局部晚期非小细胞肺癌患者诱导免疫化疗的反应相关。
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3400-3413. doi: 10.1007/s00259-023-06298-x. Epub 2023 Jun 13.
8
Lesion Analysis in PERCIST 1.0: Clinical Ease versus Research Requisite-Where Does the Balance Exist?PERCIST 1.0中的病灶分析:临床便利性与研究必要性——平衡点在哪里?
World J Nucl Med. 2023 Apr 28;22(2):100-107. doi: 10.1055/s-0042-1750406. eCollection 2023 Jun.
9
A neuroendocrine tumor within an anterior mediastinal mature teratoma: a case report.前纵隔成熟畸胎瘤内的神经内分泌肿瘤:病例报告。
J Cardiothorac Surg. 2022 Dec 22;17(1):333. doi: 10.1186/s13019-022-02091-3.
10
Comparison between a dual-time-window protocol and other simplified protocols for dynamic total-body F-FDG PET imaging.双时窗协议与其他简化协议用于动态全身F-FDG PET成像的比较。
EJNMMI Phys. 2022 Sep 14;9(1):63. doi: 10.1186/s40658-022-00492-w.